↓ Skip to main content

Advances in treating HER2-positive breast cancer: an interview with Sunil Verma

Overview of attention for article published in BMC Medicine, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
7 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Advances in treating HER2-positive breast cancer: an interview with Sunil Verma
Published in
BMC Medicine, August 2014
DOI 10.1186/s12916-014-0129-y
Pubmed ID
Authors

Sunil Verma

Abstract

In this podcast, we talk to Dr Sunil Verma about the evolution of HER2 as a therapeutic target in breast cancer, and about how targeted therapy has revolutionized breast cancer treatment. We also discuss new agents in clinical development and the ways in which advances in treating HER2-positive breast cancer can be used to inform treatment decisions in other areas of medicine.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 43%
Student > Ph. D. Student 2 29%
Student > Postgraduate 1 14%
Student > Master 1 14%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 43%
Medicine and Dentistry 3 43%
Social Sciences 1 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 September 2014.
All research outputs
#1,182,830
of 17,065,319 outputs
Outputs from BMC Medicine
#915
of 2,675 outputs
Outputs of similar age
#15,511
of 200,500 outputs
Outputs of similar age from BMC Medicine
#2
of 8 outputs
Altmetric has tracked 17,065,319 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,675 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.1. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,500 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.